Top medical experts have provided their assessment of the Nipah virus following the implementation of passenger screenings at airports in Thailand and Nepal. These screenings were put in place for travelers arriving from West Bengal, India, after two cases of the virus were confirmed in the region. Nipah is a disease that leads to brain swelling and can be transmitted from animals to humans, as well as through contaminated food and direct human contact. The virus has a high fatality rate, ranging from 40% to 75%.
In the UK, there have been no reported cases of the Nipah virus. The UK Health Security Agency’s travel chief stated that the government is closely monitoring the situation and considers the risk of an imported case into the UK to be very low.
Dr. Meera Chand, Deputy Director at UKHSA, emphasized that the agency is actively monitoring the situation and collaborating with international partners to gather the latest information on the outbreak. Dr. Chand highlighted that Nipah virus has never been reported in the UK, and the chances of transmission within the general UK population are minimal due to established protocols for isolating cases, rapid diagnostics, and infection control measures in healthcare settings.
Dr. Kaja Abbas, an Associate Professor specializing in Infectious Disease Epidemiology, explained that the structure of the Nipah virus makes widespread pandemic spread unlikely, similar to Covid-19. The virus, first identified in 1999, causes severe respiratory and neurological illnesses in humans and has led to sporadic outbreaks, particularly in Bangladesh and India.
India’s health ministry confirmed two cases of Nipah in West Bengal among healthcare workers, with no further infections reported in traced contacts. To prevent international spread, countries like Thailand and Nepal have initiated passenger screenings for individuals arriving from India, while Kazakhstan has advised medical observation for 14 days upon entry. General preventive measures focus on good hygiene, ventilation, avoiding crowds and sick individuals, seeking timely medical attention, and maintaining a healthy lifestyle to boost immunity.
The Nipah virus’s basic reproduction number indicates limited human-to-human transmission and a low risk of widespread pandemic spread. Symptoms typically start with flu-like illness or fever, and can progress to pneumonia or other respiratory complications. The most severe risk from Nipah is encephalitis or meningitis, which can develop within 3 to 21 days of the initial infection, contributing to the virus’s high mortality rate.
Between 40% and 75% of Nipah virus-infected individuals succumb to the disease, with survivors potentially experiencing long-term neurological issues like seizures and personality changes. In some cases, the virus can become reactivated months or even years after the initial infection.
